Literature DB >> 1967484

Sulpiride-induced tardive dystonia.

L G Miller1, J Jankovic.   

Abstract

Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride-induced tardive dystonia.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1967484     DOI： 10.1002/mds.870050119

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  4 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 2.  A risk-benefit assessment of sulpiride in the treatment of schizophrenia.

Authors:  M C Mauri; S Bravin; A Bitetto; R Rudelli; G Invernizzi
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

3.  Veralipride-induced tardive dystonia in a patient with bipolar psychosis.

Authors:  A S Gabellini; A Pezzoli; P De Massis; T Sacquegna
Journal:  Ital J Neurol Sci       Date:  1992-10

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.